Follow up of lung transplant recipients using an electronic nose

Journal of Breath Research

Volumn 7, Issue 1, 2013, Pages

  Kovacs, Dorottya ^a   Bikov, Andras ^a   Losonczy, Gyorgy ^a   Murakozy, Gabriella ^a   Horvath, Ildiko ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TACROLIMUS; VOLATILE ORGANIC COMPOUND; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTRONIC NOSE; EXHALATION; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; LUNG TRANSPLANTATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ANALYSIS OF VARIANCE; BLOOD; BREATH ANALYSIS; CASE CONTROL STUDY; EQUIPMENT; PRINCIPAL COMPONENT ANALYSIS; STATISTICAL MODEL;

ADULT; ANALYSIS OF VARIANCE; BREATH TESTS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LINEAR MODELS; LUNG TRANSPLANTATION; PRINCIPAL COMPONENT ANALYSIS; ROC CURVE; TACROLIMUS;

EID: 84874907230     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/7/1/017117     Document Type: Article

References (46)

1. Woo M S 2008 Overview of lung transplantation Clin. Rev. Allergy Immunol. 35 154-63
2. Hardy J D 1999 The first lung transplant in man (1963) and the first heart transplant in man (1964) Transplant. Proc. 31 25-9 (Pubitemid 29127353)
3. Lau C and Patterson G 2003 Current status of lung transplantation Eur. Respir. J. Suppl. 47 57-64
4. Horvath I, Lazar Z, Gyulai N, Kollai M and Losonczy G 2009 Exhaled biomarkers in lung cancer Eur. Respir. J. 34 261-75
5. Antus B, Barta I, Kullmann T, Lazar Z, Valyon M, Horvath I and Csiszer E 2010 Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: a longitudinal study Am. J. Respir. Crit. Care Med. 182 1492-7
6. Fens N, Roldaan A C, van der Schee M P, Boksem R J, Zwinderman A H, Bel E H and Sterk P J 2011 External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease Clin. Exp. Allergy 41 1371-8
7. Phillips M, Gleeson K, Hughes J M, Greenberg J, Cataneo R N, Baker L and McVay W P 1999 Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study Lancet 353 1930-3 (Pubitemid 29255706)
8. Phillips M, Cataneo R N, Cheema T and Greenberg J 2004 Increased breath biomarkers of oxidative stress in diabetes mellitus Clin. Chim. Acta 344 189-94 (Pubitemid 38626154)
9. Voss A, Baier V, Reisch R, von Roda K, Elsner P, Ahlers H and Stein G 2005 Smelling renal dysfunction via electronic nose Ann. Biomed. Eng. 33 656-60 (Pubitemid 40890926)
10. Filipiak W et al 2012 Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants J. Breath Res. 29 036008
11. Bikov A, Pako J, Kovacs D, Tamasi L, Lazar Z S, Rigo J, Losonczy G and Horvath I 2011 Exhaled breath volatile alterations in pregnancy assessed with electronic nose Biomarkers 16 476-84
12. Hockstein N G, Thaler E R, Lin Y, Lee D D and Hanson C W 2005 Correlation of pneumonia score with electronic nose signature: a prospective study Ann. Otol. Rhinol. Laryngol. 114 504-8 (Pubitemid 40995032)
13. Phillips M, Cataneo R N, Chaturvedi A, Danaher P J, Devadiga A, Legendre D A, Nail K L, Schmitt P and Wai J 2010 Effect of influenza vaccination on oxidative stress products in breath J. Breath Res. 4 026001
14. Weigt S S, Wallace W D, Derhovanessian A, Saggar R, Lynch J P and Belpeiro J 2010 A chronic allograft rejection: epidemiology, diagnosis, pathogenesis and treatment Semin. Respir. Crit. Care Med. 31 189-207
15. Remund K F, Best M and Egan J J 2009 Infections relevant to lung transplantation Proc. Am. Thorac. Soc. 6 94-100
16. Studer S M, Orens J B, Rosas I O, Krishan J A, Cope K A, Yang S, Conte J V, Becker P B and Risby T H 2001 Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection J. Heart Lung Transplant. 20 1158-66 (Pubitemid 33035077)
17. Gabbay E, Walters E H, Orsida B, Whitford H, Ward C, Kotsimbos T C, Snell G I and Williams T J 2000 Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase Am. J. Respir. Crit. Care Med. 162 2182-7 (Pubitemid 32051684)
18. Gabbay E, Walters E H, Orsida B, Whitford H, Ward C, Kotsimbos T C, Snell G I and Williams T J 1999 In stable lung transplant recipients, exhaled nitric oxide levels positively correlate with airway neutrophilia and bronchial epithelial iNOS Am. J. Respir. Crit. Care Med. 160 2093-9 (Pubitemid 30004724)
19. Silkoff P E, Caramori M, Tremblay L, McClean P, Chaparro C, Kesten S, Hutcheon M, Slutsky A S, Zamel N and Keshavjee S 1998 Exhaled nitric oxide in human lung transplantation: a noninvasive marker of acute rejection Am. J. Respir. Crit. Care Med. 157 1822-8
20. Miller M R et al 2005 Standardisation of spirometry Eur. Respir. J. 26 319-38 (Pubitemid 41079078)
21. Phillips M et al 2004 Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study) J. Heart Lung Transplant. 23 701-8 (Pubitemid 38721439)
22. Antus B, Csiszer E, Czebe K and Horvath I 2005 Pulmonary infections increase exhaled nitric oxide in lung transplant recipients: a longitudinal study Clin. Transplant. 19 377-82 (Pubitemid 40711974)
23. Todd J L and Palmer S M 2011 Bronchiolitis obliterans syndrome: the final frontier for lung transplantation Chest 140 502-8
24. Yates D H, Krishnan A, Chow S and Thomas P S 2011 Non-invasive assessment of exhaled biomarkers in lung transplantation J. Breath Res. 5 024001
25. Neurohra C et al 2011 Usefulness of exhaled nitric oxide to guide risk stratification for bronchiolitis obliterans syndrome after lung transplantation Am. J. Transplant. 11 129-37
26. Gajdocsy R and Horvath I 2010 Exhaled carbon monoxide in airway diseases: from research findings to clinical relevance J. Breath Res. 4 047102
27. Vos R, Cordemans C, Vanaudenaerde B M, De Vleeschauwer S I, Schoonis A, Van Raemdonck D E, Dupont L J and Verleden G M 2009 Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation Transplantation 87 1579-83
28. Kastelijn E, Rijkers G, van Moorsel C H, Zanen P, Kwakkel-van Erp J M, Van De Graaf E A, Van Kessel D A, Grutters J C and Van Den Bosch J M 2010 Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome J. Heart Lung Transplant. 29 997-1008
29. Jackson A S, Sandrini A, Campbell C, Chow S, Thomas P S and Yates D H 2007 Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage Am. J. Respir. Crit. Care Med. 175 222-7 (Pubitemid 46203124)
30. Dressel H, Müller F, Fischer R, Römmelt H, Hohlfeld J M, Behr J, Hubert R M, Nowak D and Jörres R A 2010 Independent information of nonspecific biomarkers in exhaled breath condensate Respiration 80 401-9
31. Czebe K, Kullmann T, Csiszer E, Barat E, Horvath I and Antus B 2008 Variability of exhaled breath condensate pH in lung transplant recipients Respiration 75 322-7 (Pubitemid 351450404)
32. Dupont L J, Dewandeleer Y, Vanaudenaerde B M, Van Raemdonck D E and Verleden G M 2006 The pH of exhaled breath condensate of patients with allograft rejection after lung transplantation Am. J. Transplant. 6 1486-92 (Pubitemid 44030334)
33. Soter S, Kelemen K, Barta I, Valyon M, Csiszer E and Antus B 2011 Exhaled breath condensate pH in lung transplant recipients with bronchiolitis obliterans syndrome Transplantation 91 793-7
34. Lewis N S 2004 Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors Acc. Chem. Res. 37 663-72
35. Simon M S, David J and Zulfiqur A 2007 Data analysis for electronic nose systems Microchim. Acta 156 183-207
36. Schaller E, Bosset J O and Escher F 1998 'Electronic noses' and their application to food LWT-Food. Sci. Technol. 31 305-16 (Pubitemid 128348415)
37. David J, Simon M S, Zulfiqur A and O'hare W T 2005 Chemical sensors for electronic nose systems Microchim. Acta 149 1-17 (Pubitemid 40179092)
38. Bikov A, Lazar Z, Schandl K, Antus B, Losonczy G and Horvath I 2011 Exercise changes volatiles in exhaled breath assessed by an electronic nose Acta Physiol. Hung. 98 321-8
39. Pleil J D 2009 Influence of systems biology response and environmental exposure level on between-subject variability in breath and blood biomarkers Biomarkers 14 560-71
40. Mitsubayashi K, Matsunaga H, Nishio G, Toda S and Nakanishi Y 2005 Bioelectronic sniffers for ethanol and acetaldehyde in breath air after drinking Biosens. Bioelectron. 20 1573-9 (Pubitemid 40051244)
41. Chapman E A, Thomas P S, Stone E, Lewis C and Yates D H 2012 A breath test for malignant mesothelioma using an electronic nose Eur. Respir. J. 40 448-54
42. Snell G I and Westall G P 2007 Immunosuppression for lung transplantation: evidence to date Drugs 67 1531-9 (Pubitemid 47267296)
43. Iwasaki K 2007 Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics Drug Metab. Pharmacokinet. 22 328-35
44. Staatz C E, Goodman L K and Tett S E 2010 Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part I Clin. Pharmacokinet. 49 207-21
45. Staatz C E, Goodman L K and Tett S E 2010 Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part II Clin. Pharmacokinet. 49 141-75
46. Mattison L K, Fourie J, Hirao Y, Koga T, Desmond R A, King J R, Shimizu T and Diasio R B 2006 The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity: pharmacokinetic relationship between expired 13CO2 and plasma [2-13C] dihydrouracil Clin. Cancer Res. 12 549-55 (Pubitemid 43166148)